<p>Grade 3/4 toxic reactions synchronous combined therapy vs. chemotherapy or EGFR TKIs alone.</p
<p>The incidence of adverse reactions in TCMBT plus ultraviolet irradiation compared to ultraviolet ...
<p>Comparison of objective tumor response rate between combined inhibition therapy and single inhibi...
<p>Treatment toxicity reported in studies using IMRT and chemotherapy for the treatment of locally a...
<p>Comparison of efficacy between combined therapy and chemotherapy or EGFR TKIs alone.</p
<p>Comparison of Grade 3–4 toxicity rates between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of grade ≥3 toxicities between addition of vandetanib to chemotherapy and chemotherapy...
<p>Grade 3 or Grade 4 complications of oral cancer treated with LDR vs. HDR brachytherapy.</p
<p>Relative risk of Grade III/IV adverse events in patients treates with TACE plus sorafenib versus ...
Background The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kina...
<p>No.: number; CT: chemotherapy; RT: radiotherapy; RCT: radiochemotherapy.</p><p>Treatment outcomes...
<p>Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.</p
Grade 3 or 4 toxicity events with possibly, probably, or definitely related to single agent AT-101 (...
Patients may present with multiple malignancies in the setting of particular environmental and occup...
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibito...
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibito...
<p>The incidence of adverse reactions in TCMBT plus ultraviolet irradiation compared to ultraviolet ...
<p>Comparison of objective tumor response rate between combined inhibition therapy and single inhibi...
<p>Treatment toxicity reported in studies using IMRT and chemotherapy for the treatment of locally a...
<p>Comparison of efficacy between combined therapy and chemotherapy or EGFR TKIs alone.</p
<p>Comparison of Grade 3–4 toxicity rates between GEM combination therapy and GEM alone therapy.</p
<p>Comparison of grade ≥3 toxicities between addition of vandetanib to chemotherapy and chemotherapy...
<p>Grade 3 or Grade 4 complications of oral cancer treated with LDR vs. HDR brachytherapy.</p
<p>Relative risk of Grade III/IV adverse events in patients treates with TACE plus sorafenib versus ...
Background The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kina...
<p>No.: number; CT: chemotherapy; RT: radiotherapy; RCT: radiochemotherapy.</p><p>Treatment outcomes...
<p>Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.</p
Grade 3 or 4 toxicity events with possibly, probably, or definitely related to single agent AT-101 (...
Patients may present with multiple malignancies in the setting of particular environmental and occup...
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibito...
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibito...
<p>The incidence of adverse reactions in TCMBT plus ultraviolet irradiation compared to ultraviolet ...
<p>Comparison of objective tumor response rate between combined inhibition therapy and single inhibi...
<p>Treatment toxicity reported in studies using IMRT and chemotherapy for the treatment of locally a...
DOI
Add to ORKG